Skip to main content

Find Clinical Trials

Home
Conditions
Nasopharyngeal Neoplasms

Clinical trial condition

Nasopharyngeal Neoplasms

Explore clinical trials studying Nasopharyngeal Neoplasms. Study availability and eligibility vary by location and protocol.

336 public trials 129 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Neoplasms trial results

Completed

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

NCT03674567

Conditions: Advanced Cancer, Breast Diseases, Breast Neoplasms, +44 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

City of Hope Duarte, California, United States

University of California, Los Angeles JCCC Clinical Research Unit Los Angeles, California, United States

Yale Cancer Center New Haven, Connecticut, United States

View all 35 locations

View Trial Details

Completed

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

NCT05292027

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sichuan Cancer Hospital Chengdu, Sichuan, China

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)

NCT04996758

Conditions: Carcinoma, Disease Attributes, Head and Neck Neoplasms, +16 more
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University Guangzhou, China

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

NCT03474640

Conditions: Adenocarcinoma, Advanced Malignancies, Carcinoma, +28 more
Locations: Sarcoma Oncology Research Center Santa Monica, California, United States

University of Colorado Denver Aurora, Colorado, United States

University of Miami Hospital Sylvester Comprehensive Cancer Center Miami, Florida, United States

Florida Cancer Specialists Sarasota, Florida, United States

View all 14 locations

View Trial Details

Completed

Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal Carcinoma

NCT06676293

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Chang Gung Memorial Hospital Taoyuan City, Taiwan

View Trial Details

Completed

Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer

NCT04870840

Conditions: Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +35 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma

NCT04895345

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Hospital Guangzhou, Guangdong, China

View Trial Details

Completed

A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma

NCT04220307

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma

NCT04417985

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Not specified

View Trial Details